Skip to main content
Erschienen in: European Journal of Nutrition 1/2023

19.08.2022 | Review

Energy balance in cancer survivors at risk of weight gain: a review

verfasst von: Jessica McNeil

Erschienen in: European Journal of Nutrition | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The study of energy balance [i.e., energy intake (EI) and energy expenditure (EE)] is a powerful tool for understanding body weight regulation and may contribute to our understanding of rapid weight gain risk in certain cancer survivors post-diagnosis. The purpose of this review was to summarize studies that assessed longitudinal, prospective changes in components of energy balance from diagnosis/start of treatment to any duration of follow-up in cancer survivors with prior evidence of weight gain (breast, prostate, thyroid, gynecologic, testicular, and acute lymphoblastic leukemia)

Results

The available literature suggests that energy balance components may be altered in cancer survivors who have a heightened risk of weight gain post-diagnosis. The evidence for EI was overall inconsistent. Conversely, decreases in resting and physical activity EE during the active phases of treatment (e.g., chemotherapy, hypothyroid state) were commonly noted, which then slowly rebounded towards baseline levels at the end of treatment and during follow-up assessments. Much of this evidence is based on data collected from breast cancer survivors, which highlights a paucity of data currently available on other cancer types.

Conclusions

While there is growing acknowledgement that weight management interventions in cancer survivors are needed, it is important to recognize that changes in both behavioral (EI, physical activity EE) and passive (resting EE, thermic effect of food) components of energy balance may occur post-diagnosis. This information can help to inform weight management interventions which often entail modifications in diet and/or physical activity.
Literatur
2.
Zurück zum Zitat Nechuta S, Chen WY, Cai H, Poole EM, Kwan ML, Flatt SW, Patterson RE, Pierce JP, Caan BJ, Ou Shu X (2016) A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis. Int J Cancer 138(9):2088–2097. https://doi.org/10.1002/ijc.29940CrossRef Nechuta S, Chen WY, Cai H, Poole EM, Kwan ML, Flatt SW, Patterson RE, Pierce JP, Caan BJ, Ou Shu X (2016) A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis. Int J Cancer 138(9):2088–2097. https://​doi.​org/​10.​1002/​ijc.​29940CrossRef
3.
Zurück zum Zitat Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML (2015) Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. J Natl Cancer Inst 107(12):275CrossRef Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML (2015) Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. J Natl Cancer Inst 107(12):275CrossRef
4.
Zurück zum Zitat Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, Holick CN, Hampton JM, Stampfer MJ, Willett WC, Newcomb PA (2009) Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev 18(5):1403–1409. https://doi.org/10.1158/1055-9965.Epi-08-1094CrossRef Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, Holick CN, Hampton JM, Stampfer MJ, Willett WC, Newcomb PA (2009) Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev 18(5):1403–1409. https://​doi.​org/​10.​1158/​1055-9965.​Epi-08-1094CrossRef
8.
Zurück zum Zitat Caan BJ, Kwan ML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, Poole EM, Kroenke CH, Weltzien EK, Flatt SW, Quesenberry CP Jr, Holmes MD, Chen WY (2012) Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev 21(8):1260–1271. https://doi.org/10.1158/1055-9965.Epi-12-0306CrossRef Caan BJ, Kwan ML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, Poole EM, Kroenke CH, Weltzien EK, Flatt SW, Quesenberry CP Jr, Holmes MD, Chen WY (2012) Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev 21(8):1260–1271. https://​doi.​org/​10.​1158/​1055-9965.​Epi-12-0306CrossRef
9.
Zurück zum Zitat Mutschler NS, Scholz C, Friedl TWP, Zwingers T, Fasching PA, Beckmann MW, Fehm T, Mohrmann S, Salmen J, Ziegler C, Jäger B, Widschwendter P, de Gregorio N, Schochter F, Mahner S, Harbeck N, Weissenbacher T, Jückstock J, Janni W, Rack B (2018) Prognostic impact of weight change during adjuvant chemotherapy in patients with high-risk early breast cancer: results from the ADEBAR study. Clin Breast Cancer 18(2):175–183. https://doi.org/10.1016/j.clbc.2018.01.008CrossRef Mutschler NS, Scholz C, Friedl TWP, Zwingers T, Fasching PA, Beckmann MW, Fehm T, Mohrmann S, Salmen J, Ziegler C, Jäger B, Widschwendter P, de Gregorio N, Schochter F, Mahner S, Harbeck N, Weissenbacher T, Jückstock J, Janni W, Rack B (2018) Prognostic impact of weight change during adjuvant chemotherapy in patients with high-risk early breast cancer: results from the ADEBAR study. Clin Breast Cancer 18(2):175–183. https://​doi.​org/​10.​1016/​j.​clbc.​2018.​01.​008CrossRef
11.
13.
Zurück zum Zitat Thivat E, Therondel S, Lapirot O, Abrial C, Gimbergues P, Gadea E, Planchat E, Kwiatkowski F, Mouret-Reynier MA, Chollet P, Durando X (2010) Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer 10:648. https://doi.org/10.1186/1471-2407-10-648CrossRef Thivat E, Therondel S, Lapirot O, Abrial C, Gimbergues P, Gadea E, Planchat E, Kwiatkowski F, Mouret-Reynier MA, Chollet P, Durando X (2010) Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer 10:648. https://​doi.​org/​10.​1186/​1471-2407-10-648CrossRef
15.
Zurück zum Zitat van den Berg M, Kok DE, Visser M, de Vries JHM, de Kruif J, de Vries Y, Posthuma L, Sommeijer DW, Timmer-Bonte A, Los M, van Laarhoven HWM, Kampman E, Winkels RM (2020) Changes in body composition during and after adjuvant or neo-adjuvant chemotherapy in women with breast cancer stage I-IIIB compared with changes over a similar timeframe in women without cancer. Support Care Cancer 28(4):1685–1693. https://doi.org/10.1007/s00520-019-04951-6CrossRef van den Berg M, Kok DE, Visser M, de Vries JHM, de Kruif J, de Vries Y, Posthuma L, Sommeijer DW, Timmer-Bonte A, Los M, van Laarhoven HWM, Kampman E, Winkels RM (2020) Changes in body composition during and after adjuvant or neo-adjuvant chemotherapy in women with breast cancer stage I-IIIB compared with changes over a similar timeframe in women without cancer. Support Care Cancer 28(4):1685–1693. https://​doi.​org/​10.​1007/​s00520-019-04951-6CrossRef
18.
Zurück zum Zitat Trestini I, Carbognin L, Monteverdi S, Zanelli S, De Toma A, Bonaiuto C, Nortilli R, Fiorio E, Pilotto S, Di Maio M, Gasbarrini A, Scambia G, Tortora G, Bria E (2018) Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer. Crit Rev Oncol Hematol 129:54–66. https://doi.org/10.1016/j.critrevonc.2018.06.011CrossRef Trestini I, Carbognin L, Monteverdi S, Zanelli S, De Toma A, Bonaiuto C, Nortilli R, Fiorio E, Pilotto S, Di Maio M, Gasbarrini A, Scambia G, Tortora G, Bria E (2018) Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer. Crit Rev Oncol Hematol 129:54–66. https://​doi.​org/​10.​1016/​j.​critrevonc.​2018.​06.​011CrossRef
20.
Zurück zum Zitat Wilson RL, Newton RU, Taaffe DR, Hart NH, Lyons-Wall P, Galvao DA (2021) Weight loss for obese prostate cancer patients on androgen deprivation therapy. Med Sci Sports Exerc 53(3):470–478CrossRef Wilson RL, Newton RU, Taaffe DR, Hart NH, Lyons-Wall P, Galvao DA (2021) Weight loss for obese prostate cancer patients on androgen deprivation therapy. Med Sci Sports Exerc 53(3):470–478CrossRef
21.
Zurück zum Zitat Grossmann M, Hamilton EJ, Gilfillan C, Bolton D, Joon DL, Zajac JD (2011) Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy. Med J Aust 194(6):301–306CrossRef Grossmann M, Hamilton EJ, Gilfillan C, Bolton D, Joon DL, Zajac JD (2011) Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy. Med J Aust 194(6):301–306CrossRef
23.
Zurück zum Zitat Imayama I, Alfano CM, Neuhouser ML, George SM, Wilder Smith A, Baumgartner RN, Baumgartner KB, Bernstein L, Wang CY, Duggan C, Ballard-Barbash R, McTiernan A (2013) Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors. Breast Cancer Res Treat 140(1):159–176. https://doi.org/10.1007/s10549-013-2594-yCrossRef Imayama I, Alfano CM, Neuhouser ML, George SM, Wilder Smith A, Baumgartner RN, Baumgartner KB, Bernstein L, Wang CY, Duggan C, Ballard-Barbash R, McTiernan A (2013) Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors. Breast Cancer Res Treat 140(1):159–176. https://​doi.​org/​10.​1007/​s10549-013-2594-yCrossRef
26.
Zurück zum Zitat Kwok A, Palermo C, Boltong A (2015) Dietary experiences and support needs of women who gain weight following chemotherapy for breast cancer. Support Care Cancer 23(6):1561–1568CrossRef Kwok A, Palermo C, Boltong A (2015) Dietary experiences and support needs of women who gain weight following chemotherapy for breast cancer. Support Care Cancer 23(6):1561–1568CrossRef
27.
Zurück zum Zitat DemarkWahnefried W, Rimer BK, Winer EP (1997) Weight gain in women diagnosed with breast cancer. J Am Diet Assoc 97(5):519CrossRef DemarkWahnefried W, Rimer BK, Winer EP (1997) Weight gain in women diagnosed with breast cancer. J Am Diet Assoc 97(5):519CrossRef
29.
31.
Zurück zum Zitat de Kruif AJ, Westerman MJ, Winkels RM, Koster MS, van der Staaij IM, van den Berg MMGA, de Vries JHM, de Boer MR, Kampman E, Visser M (2021) Exploring changes in dietary intake, physical activity and body weight during chemotherapy in women with breast cancer: a Mixed-Methods Study. J Hum Nutr Diet 34(3):550–561. https://doi.org/10.1111/jhn.12843CrossRef de Kruif AJ, Westerman MJ, Winkels RM, Koster MS, van der Staaij IM, van den Berg MMGA, de Vries JHM, de Boer MR, Kampman E, Visser M (2021) Exploring changes in dietary intake, physical activity and body weight during chemotherapy in women with breast cancer: a Mixed-Methods Study. J Hum Nutr Diet 34(3):550–561. https://​doi.​org/​10.​1111/​jhn.​12843CrossRef
35.
Zurück zum Zitat Fadelu TMDMPH, Damuse RMD, Lormil JMD, Pecan EMBA, Greenberg LBA, Dubuisson C, Pierre VRN, Triedman SAMD, Shulman LNMD, Rebbeck TRP (2020) Body mass index, chemotherapy-related weight changes, and disease-free survival in haitian women with nonmetastatic breast cancer. JCO Glob Oncol 6:1656–1665CrossRef Fadelu TMDMPH, Damuse RMD, Lormil JMD, Pecan EMBA, Greenberg LBA, Dubuisson C, Pierre VRN, Triedman SAMD, Shulman LNMD, Rebbeck TRP (2020) Body mass index, chemotherapy-related weight changes, and disease-free survival in haitian women with nonmetastatic breast cancer. JCO Glob Oncol 6:1656–1665CrossRef
36.
Zurück zum Zitat Pedersini R, di Mauro P, Bosio S, Zanini B, Zanini A, Amoroso V, Turla A, Vassalli L, Ardine M, Monteverdi S, Zamparini M, Gurizzan C, Cosentini D, Ricci C, Simoncini EL, Berruti A (2021) Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy. Sci Rep 11(1):12975–12975. https://doi.org/10.1038/s41598-021-92138-7CrossRef Pedersini R, di Mauro P, Bosio S, Zanini B, Zanini A, Amoroso V, Turla A, Vassalli L, Ardine M, Monteverdi S, Zamparini M, Gurizzan C, Cosentini D, Ricci C, Simoncini EL, Berruti A (2021) Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy. Sci Rep 11(1):12975–12975. https://​doi.​org/​10.​1038/​s41598-021-92138-7CrossRef
43.
Zurück zum Zitat Broeders EPM, Vijgen GHEJ, Havekes B, Bouvy ND, Mottaghy FM, Kars M, Schaper NC, Schrauwen P, Brans B, Van Marken Lichtenbelt WD (2016) Thyroid hormone activates brown adipose tissue and increases non-shivering thermogenesis—a cohort study in a group of thyroid carcinoma patients. PLoS ONE 11:e0145049. https://doi.org/10.1371/journal.pone.0145049CrossRef Broeders EPM, Vijgen GHEJ, Havekes B, Bouvy ND, Mottaghy FM, Kars M, Schaper NC, Schrauwen P, Brans B, Van Marken Lichtenbelt WD (2016) Thyroid hormone activates brown adipose tissue and increases non-shivering thermogenesis—a cohort study in a group of thyroid carcinoma patients. PLoS ONE 11:e0145049. https://​doi.​org/​10.​1371/​journal.​pone.​0145049CrossRef
49.
Zurück zum Zitat Garmey EG, Liu Q, Sklar CA, Meacham LR, Mertens AC, Stovall MA, Yasui Y, Robison LL, Oeffinger KC (2008) Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 26(28):4639–4645. https://doi.org/10.1200/jco.2008.16.3527CrossRef Garmey EG, Liu Q, Sklar CA, Meacham LR, Mertens AC, Stovall MA, Yasui Y, Robison LL, Oeffinger KC (2008) Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 26(28):4639–4645. https://​doi.​org/​10.​1200/​jco.​2008.​16.​3527CrossRef
50.
Zurück zum Zitat Withycombe JS, Smith LM, Meza JL, Merkle C, Faulkner MS, Ritter L, Seibel NL, Moore K (2015) Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children’s Oncology Group. Pediatr Blood Cancer 62(3):434–439. https://doi.org/10.1002/pbc.25316CrossRef Withycombe JS, Smith LM, Meza JL, Merkle C, Faulkner MS, Ritter L, Seibel NL, Moore K (2015) Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children’s Oncology Group. Pediatr Blood Cancer 62(3):434–439. https://​doi.​org/​10.​1002/​pbc.​25316CrossRef
57.
Zurück zum Zitat Kutynec CL, McCargar L, Barr SI, Hislop TG (1999) Energy balance in women with breast cancer during adjuvant treatment. J Am Diet Assoc 99(10):1222–1227CrossRef Kutynec CL, McCargar L, Barr SI, Hislop TG (1999) Energy balance in women with breast cancer during adjuvant treatment. J Am Diet Assoc 99(10):1222–1227CrossRef
59.
Zurück zum Zitat Del Rio G, Zironi S, Valeriani L, Menozzi R, Bondi M, Bertolini M, Piccinini L, Banzi MC, Federico M (2002) Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition. Breast Cancer Res Treat 73(3):267–273CrossRef Del Rio G, Zironi S, Valeriani L, Menozzi R, Bondi M, Bertolini M, Piccinini L, Banzi MC, Federico M (2002) Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition. Breast Cancer Res Treat 73(3):267–273CrossRef
61.
Zurück zum Zitat Gordon AM, Hurwitz S, Shapiro CL, LeBoff MS (2011) Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer. Menopause 18(11):1244–1248CrossRef Gordon AM, Hurwitz S, Shapiro CL, LeBoff MS (2011) Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer. Menopause 18(11):1244–1248CrossRef
62.
Zurück zum Zitat Brunvoll SH, Thune I, Bertheussen GF, Fjeldheim F, Flote VG, Frydenberg H, Lundgren S, Skjerven H, Lomo J, Fagerland MW, McTiernan A, Schlichting E, Hjartaker A (2021) Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery. Br J Nutr 125(2):172–182. https://doi.org/10.1017/s0007114520002627CrossRef Brunvoll SH, Thune I, Bertheussen GF, Fjeldheim F, Flote VG, Frydenberg H, Lundgren S, Skjerven H, Lomo J, Fagerland MW, McTiernan A, Schlichting E, Hjartaker A (2021) Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery. Br J Nutr 125(2):172–182. https://​doi.​org/​10.​1017/​s000711452000262​7CrossRef
66.
Zurück zum Zitat Phillips SM, Welch WA, Fanning J, Santa-Maria CA, Gavin KL, Auster-Gussman LA, Solk P, Lu M, Cullather E, Khan SA, Kulkarni SA, Gradishar W, Siddique J (2020) Daily physical activity and symptom reporting in breast cancer patients undergoing chemotherapy: an intensive longitudinal examination. Cancer Epidemiol Biomarkers Prev 29(12):2608–2616. https://doi.org/10.1158/1055-9965.Epi-20-0659CrossRef Phillips SM, Welch WA, Fanning J, Santa-Maria CA, Gavin KL, Auster-Gussman LA, Solk P, Lu M, Cullather E, Khan SA, Kulkarni SA, Gradishar W, Siddique J (2020) Daily physical activity and symptom reporting in breast cancer patients undergoing chemotherapy: an intensive longitudinal examination. Cancer Epidemiol Biomarkers Prev 29(12):2608–2616. https://​doi.​org/​10.​1158/​1055-9965.​Epi-20-0659CrossRef
73.
Zurück zum Zitat Ladas EJ, Orjuela M, Stevenson K, Cole PD, Lin M, Athale UH, Clavell LA, Leclerc JM, Laverdiere C, Michon B, Schorin MA, Welch JG, Asselin BL, Sallan SE, Silverman LB, Kelly KM (2019) Fluctuations in dietary intake during treatment for childhood leukemia: a report from the DALLT cohort. Clinical Nutr 38(6):2866–2874. https://doi.org/10.1016/j.clnu.2018.12.021CrossRef Ladas EJ, Orjuela M, Stevenson K, Cole PD, Lin M, Athale UH, Clavell LA, Leclerc JM, Laverdiere C, Michon B, Schorin MA, Welch JG, Asselin BL, Sallan SE, Silverman LB, Kelly KM (2019) Fluctuations in dietary intake during treatment for childhood leukemia: a report from the DALLT cohort. Clinical Nutr 38(6):2866–2874. https://​doi.​org/​10.​1016/​j.​clnu.​2018.​12.​021CrossRef
82.
Zurück zum Zitat Smith JC, Bennett S, Evans LM, Kynaston HG, Parmar M, Mason MD, Cockcroft JR, Scanlon MF, Davies JS (2001) The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab 86(9):4261–4267. https://doi.org/10.1210/jcem.86.9.7851CrossRef Smith JC, Bennett S, Evans LM, Kynaston HG, Parmar M, Mason MD, Cockcroft JR, Scanlon MF, Davies JS (2001) The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab 86(9):4261–4267. https://​doi.​org/​10.​1210/​jcem.​86.​9.​7851CrossRef
85.
Zurück zum Zitat Diamond T, Campbell J, Bryant C, Lynch W (1998) The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer 83(8):1561–1566CrossRef Diamond T, Campbell J, Bryant C, Lynch W (1998) The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer 83(8):1561–1566CrossRef
86.
Zurück zum Zitat Carlstrom K, Pousette A, Stege R (1990) Flutamide has no effect on adrenal androgen response to acute ACTH stimulation in patients with prostatic cancer. Prostate 17(3):219–225CrossRef Carlstrom K, Pousette A, Stege R (1990) Flutamide has no effect on adrenal androgen response to acute ACTH stimulation in patients with prostatic cancer. Prostate 17(3):219–225CrossRef
88.
Zurück zum Zitat Reis C, Liberman S, Pompeo AC, Srougi M, Halpern A, Filho WJ (2009) Body composition alterations, energy expenditure and fat oxidation in elderly males suffering from prostate cancer, pre and post orchiectomy. Clinics 64(8):781–784CrossRef Reis C, Liberman S, Pompeo AC, Srougi M, Halpern A, Filho WJ (2009) Body composition alterations, energy expenditure and fat oxidation in elderly males suffering from prostate cancer, pre and post orchiectomy. Clinics 64(8):781–784CrossRef
90.
Zurück zum Zitat Smith L, Lee JA, Mun J, Pakpahan R, Imm KR, Izadi S, Kibel AS, Colditz GA, Grubb RL 3rd, Wolin KY, Sutcliffe S, Yang L (2019) Levels and patterns of self-reported and objectively-measured free-living physical activity among prostate cancer survivors: A prospective cohort study. Cancer 125(5):798–806. https://doi.org/10.1002/cncr.31857CrossRef Smith L, Lee JA, Mun J, Pakpahan R, Imm KR, Izadi S, Kibel AS, Colditz GA, Grubb RL 3rd, Wolin KY, Sutcliffe S, Yang L (2019) Levels and patterns of self-reported and objectively-measured free-living physical activity among prostate cancer survivors: A prospective cohort study. Cancer 125(5):798–806. https://​doi.​org/​10.​1002/​cncr.​31857CrossRef
97.
Zurück zum Zitat Ijpma I, Renken RJ, Gietema JA, Slart R, Mensink MGJ, Lefrandt JD, Ter Horst GJ, Reyners AKL (2017) Changes in taste and smell function, dietary intake, food preference, and body composition in testicular cancer patients treated with cisplatin-based chemotherapy. Clin Nutr 36(6):1642–1648. https://doi.org/10.1016/j.clnu.2016.10.013CrossRef Ijpma I, Renken RJ, Gietema JA, Slart R, Mensink MGJ, Lefrandt JD, Ter Horst GJ, Reyners AKL (2017) Changes in taste and smell function, dietary intake, food preference, and body composition in testicular cancer patients treated with cisplatin-based chemotherapy. Clin Nutr 36(6):1642–1648. https://​doi.​org/​10.​1016/​j.​clnu.​2016.​10.​013CrossRef
99.
Zurück zum Zitat Fleming S, Jones T, Janda M, Vagenas D, Ward L, Reul-Hirche H, Sandler C, Obermair A, Hayes S (2020) Physical activity trajectories following gynecological cancer: results from a prospective, longitudinal cohort study. Int J Gynecol Cancer 30(11):1784–1790. https://doi.org/10.1136/ijgc-2020-001543CrossRef Fleming S, Jones T, Janda M, Vagenas D, Ward L, Reul-Hirche H, Sandler C, Obermair A, Hayes S (2020) Physical activity trajectories following gynecological cancer: results from a prospective, longitudinal cohort study. Int J Gynecol Cancer 30(11):1784–1790. https://​doi.​org/​10.​1136/​ijgc-2020-001543CrossRef
102.
105.
106.
Zurück zum Zitat Skolarus TA, Wolf AM, Erb NL, Brooks DD, Rivers BM, Underwood W 3rd, Salner AL, Zelefsky MJ, Aragon-Ching JB, Slovin SF, Wittmann DA, Hoyt MA, Sinibaldi VJ, Chodak G, Pratt-Chapman ML, Cowens-Alvarado RL (2014) American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin 64(4):225–249. https://doi.org/10.3322/caac.21234CrossRef Skolarus TA, Wolf AM, Erb NL, Brooks DD, Rivers BM, Underwood W 3rd, Salner AL, Zelefsky MJ, Aragon-Ching JB, Slovin SF, Wittmann DA, Hoyt MA, Sinibaldi VJ, Chodak G, Pratt-Chapman ML, Cowens-Alvarado RL (2014) American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin 64(4):225–249. https://​doi.​org/​10.​3322/​caac.​21234CrossRef
107.
Zurück zum Zitat Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 66(1):43–73. https://doi.org/10.3322/caac.21319CrossRef Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 66(1):43–73. https://​doi.​org/​10.​3322/​caac.​21319CrossRef
108.
Zurück zum Zitat Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, Byers T, Gansler T (2012) Nutrition and physical activity guidelines for cancer survivors. CA: Cancer J Clin 62(4):243–274. https://doi.org/10.3322/caac.21142CrossRef Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, Byers T, Gansler T (2012) Nutrition and physical activity guidelines for cancer survivors. CA: Cancer J Clin 62(4):243–274. https://​doi.​org/​10.​3322/​caac.​21142CrossRef
109.
Zurück zum Zitat Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Oldervoll L, Ravasco P, Solheim TS, Strasser F, de van der Schueren M, Preiser JC, Bischoff SC (2021) ESPEN practical guideline: Clinical Nutrition in cancer. Clinical Nutr 40(5):2898–2913. https://doi.org/10.1016/j.clnu.2021.02.005CrossRef Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Oldervoll L, Ravasco P, Solheim TS, Strasser F, de van der Schueren M, Preiser JC, Bischoff SC (2021) ESPEN practical guideline: Clinical Nutrition in cancer. Clinical Nutr 40(5):2898–2913. https://​doi.​org/​10.​1016/​j.​clnu.​2021.​02.​005CrossRef
112.
Zurück zum Zitat de Vries YC, Winkels RM, van den Berg M, de Graaf C, Kelfkens CS, de Kruif J, Goker E, Grosfeld S, Sommeijer DW, van Laarhoven HWM, Kampman E, Boesveldt S (2018) Altered food preferences and chemosensory perception during chemotherapy in breast cancer patients: a longitudinal comparison with healthy controls. Food Qual Prefer 63:135–143. https://doi.org/10.1016/j.foodqual.2017.09.003CrossRef de Vries YC, Winkels RM, van den Berg M, de Graaf C, Kelfkens CS, de Kruif J, Goker E, Grosfeld S, Sommeijer DW, van Laarhoven HWM, Kampman E, Boesveldt S (2018) Altered food preferences and chemosensory perception during chemotherapy in breast cancer patients: a longitudinal comparison with healthy controls. Food Qual Prefer 63:135–143. https://​doi.​org/​10.​1016/​j.​foodqual.​2017.​09.​003CrossRef
113.
Zurück zum Zitat Steinbach S, Hummel T, Böhner C, Berktold S, Hundt W, Kriner M, Heinrich P, Sommer H, Hanusch C, Prechtl A, Schmidt B, Bauerfeind I, Seck K, Jacobs VR, Schmalfeldt B, Harbeck N (2009) Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol 27(11):1899–1905. https://doi.org/10.1200/jco.2008.19.2690CrossRef Steinbach S, Hummel T, Böhner C, Berktold S, Hundt W, Kriner M, Heinrich P, Sommer H, Hanusch C, Prechtl A, Schmidt B, Bauerfeind I, Seck K, Jacobs VR, Schmalfeldt B, Harbeck N (2009) Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol 27(11):1899–1905. https://​doi.​org/​10.​1200/​jco.​2008.​19.​2690CrossRef
Metadaten
Titel
Energy balance in cancer survivors at risk of weight gain: a review
verfasst von
Jessica McNeil
Publikationsdatum
19.08.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 1/2023
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-022-02975-z

Weitere Artikel der Ausgabe 1/2023

European Journal of Nutrition 1/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.